Asif Ali - 02 Jan 2024 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role: Chief Financial Officer
Signature: /s/ Matthew Gosling, Attorney-in-Fact for Asif Ali
Issuer symbol: PTGX
Transactions as of: 02 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2024, 20:07:32 UTC
Previous filing: 02 Jun 2023
Next filing: 18 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTGX	Common Stock	Award	$0	+21,000	+68%	$0.000000	52,036	02 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTGX	Stock Option (right to buy)	Award	$0	+78,000		$0.000000	78,000	02 Jan 2024	Common Stock	78,000	$23.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
F2	The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.